Gå offline med appen Player FM !
Episode 37. ASH 2023 Myeloma Recap with Dr. Ben Derman
Manage episode 391922903 series 3369804
In this episode, we discuss the key abstracts in myeloma and related plasma cell disorders at ASH23 with Dr. Benjamin Derman. Here are the abstracts discussed in this episode:
First, we will focus on a few abstracts in precursor states, MGUS.
1. New diagnostic criteria for light chain MGUS (IStopMM):
https://ash.confex.com/ash/2023/webprogram/Paper188547.html
https://ash.confex.com/ash/2023/webprogram/Paper182661.html
2. PERSEUS Trial-Dara-VRD vs VRD in newly diagnosed transplant-eligible myeloma:
https://ash.confex.com/ash/2023/webprogram/Paper191911.html
3. ISKIA trial: Isa-KRD vs KRD in newly diagnosed transplant-eligible myeloma:
https://ash.confex.com/ash/2023/webprogram/Paper177546.html
4. Phase 1/2 study for Daratumumab-Venetoclax-Dexamethasone in early relapsed t(11;14) myeloma:
https://ash.confex.com/ash/2023/webprogram/Paper180766.html
5. GMMG Relapse Trial (Long-term follow-up data from randomized controlled trial of salvage transplant in myeloma)
https://ash.confex.com/ash/2023/webprogram/Paper178835.html
6. Overall survival results of KarMMa-3 trial
https://ash.confex.com/ash/2023/webprogram/Paper178933.html
7. GEM2017FIT Trial: Dara-KRd vs KRd vs VMP-RD in non-transplant eligible patients:
52 episoder
Manage episode 391922903 series 3369804
In this episode, we discuss the key abstracts in myeloma and related plasma cell disorders at ASH23 with Dr. Benjamin Derman. Here are the abstracts discussed in this episode:
First, we will focus on a few abstracts in precursor states, MGUS.
1. New diagnostic criteria for light chain MGUS (IStopMM):
https://ash.confex.com/ash/2023/webprogram/Paper188547.html
https://ash.confex.com/ash/2023/webprogram/Paper182661.html
2. PERSEUS Trial-Dara-VRD vs VRD in newly diagnosed transplant-eligible myeloma:
https://ash.confex.com/ash/2023/webprogram/Paper191911.html
3. ISKIA trial: Isa-KRD vs KRD in newly diagnosed transplant-eligible myeloma:
https://ash.confex.com/ash/2023/webprogram/Paper177546.html
4. Phase 1/2 study for Daratumumab-Venetoclax-Dexamethasone in early relapsed t(11;14) myeloma:
https://ash.confex.com/ash/2023/webprogram/Paper180766.html
5. GMMG Relapse Trial (Long-term follow-up data from randomized controlled trial of salvage transplant in myeloma)
https://ash.confex.com/ash/2023/webprogram/Paper178835.html
6. Overall survival results of KarMMa-3 trial
https://ash.confex.com/ash/2023/webprogram/Paper178933.html
7. GEM2017FIT Trial: Dara-KRd vs KRd vs VMP-RD in non-transplant eligible patients:
52 episoder
Alla avsnitt
×Välkommen till Player FM
Player FM scannar webben för högkvalitativa podcasts för dig att njuta av nu direkt. Den är den bästa podcast-appen och den fungerar med Android, Iphone och webben. Bli medlem för att synka prenumerationer mellan enheter.